Can personalized use of NSAIDs be a reality in the clinic?

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The use of NSAIDs in rheumatology could be improved by an appropriate risk scoring system that accounts for adverse events such as bleeding and thrombosis. Such a risk score has now been developed using data from the PRECISION trial, but is this score ready to be applied in clinical practice?
Original languageEnglish
Pages (from-to)387-388
JournalNature Reviews Rheumatology
Volume15
Issue number7
DOIs
Publication statusPublished - 2019

Cite this

@article{b1654a28391a4667822b3c2a666989d1,
title = "Can personalized use of NSAIDs be a reality in the clinic?",
abstract = "The use of NSAIDs in rheumatology could be improved by an appropriate risk scoring system that accounts for adverse events such as bleeding and thrombosis. Such a risk score has now been developed using data from the PRECISION trial, but is this score ready to be applied in clinical practice?",
author = "Nurmohamed, {Michael T.}",
year = "2019",
doi = "10.1038/s41584-019-0225-7",
language = "English",
volume = "15",
pages = "387--388",
journal = "Nature Reviews Rheumatology",
issn = "1759-4790",
publisher = "Nature Publishing Group",
number = "7",

}

Can personalized use of NSAIDs be a reality in the clinic? / Nurmohamed, Michael T.

In: Nature Reviews Rheumatology, Vol. 15, No. 7, 2019, p. 387-388.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Can personalized use of NSAIDs be a reality in the clinic?

AU - Nurmohamed, Michael T.

PY - 2019

Y1 - 2019

N2 - The use of NSAIDs in rheumatology could be improved by an appropriate risk scoring system that accounts for adverse events such as bleeding and thrombosis. Such a risk score has now been developed using data from the PRECISION trial, but is this score ready to be applied in clinical practice?

AB - The use of NSAIDs in rheumatology could be improved by an appropriate risk scoring system that accounts for adverse events such as bleeding and thrombosis. Such a risk score has now been developed using data from the PRECISION trial, but is this score ready to be applied in clinical practice?

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065156834&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31040441

U2 - 10.1038/s41584-019-0225-7

DO - 10.1038/s41584-019-0225-7

M3 - Article

VL - 15

SP - 387

EP - 388

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

SN - 1759-4790

IS - 7

ER -